Promising Small Cap Stocks To Add to Your Watchlist - October 18th

Key Points

• Seven Small Cap stocks, including Spring Valley Acquisition, Rani Therapeutics, and Liberty Energy, are highlighted as potential investments due to their high trading volumes and growth potential.
• Small cap stocks are characterized by their market capitalizations generally ranging from $300 million to $2 billion, offering investors higher growth potential along with increased volatility and lower liquidity.
• Rani Therapeutics is working on a unique oral delivery platform for biologics, while Artiva Biotherapeutics focuses on NK cell therapies for autoimmune diseases and cancers.

Spring Valley Acquisition, Rani Therapeutics, Veritex, Artiva Biotherapeutics, Inflection Point Acquisition Corp. II, SEALSQ, and Liberty Energy are the seven Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small-cap stocks are shares of companies with relatively small market capitalizations—typically firms valued between roughly $300 million and $2 billion, though exact cutoffs vary by index provider. For investors they often offer higher growth potential but also greater volatility, lower liquidity and less analyst coverage, making them a higher-risk, potentially higher-reward part of a diversified portfolio. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.

Spring Valley Acquisition (SV)

Read Our Latest Research Report on SV

Rani Therapeutics (RANI)

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies.

Read Our Latest Research Report on RANI

Veritex (VBTX)

Veritex Holdings, Inc. operates as the bank holding company for Veritex Community Bank that provides various commercial banking products and services to small and medium-sized businesses, and professionals. The company accepts deposit products include demand, savings, money market, and time accounts.

Read Our Latest Research Report on VBTX

Artiva Biotherapeutics (ARTV)

Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. The company's lead product candidate is AB-101, an off-the-shelf NK cell therapy for patients with autoimmune diseases and cancers, such as lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, the anti-neutrophil cytoplasmic antibody-associated vasculitis subtypes granulomatosis with polyangiitis/microscopic polyangiitis, systemic lupus erythematosus, and B-cell-non-Hodgkin lymphoma.

Read Our Latest Research Report on ARTV

Inflection Point Acquisition Corp. II (IPXX)

Read Our Latest Research Report on IPXX

SEALSQ (LAES)

SEALSQ Corp, together with its subsidiaries, designs, develops, and markets semiconductor chips in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. It offers semiconductors, such as VaultIC secure elements, secure arm platform, and smart card reader chips; identity provisioning services, such as IoT device provisioning and chip provisioning; and managed PKI for IoT solutions and trust services.

Read Our Latest Research Report on LAES

Liberty Energy (LBRT)

Liberty Energy Inc. provides hydraulic services and related technologies to onshore oil and natural gas exploration, and production companies in North America. The company offers hydraulic fracturing services, including complementary services, such as wireline services, proppant delivery solutions, field gas processing and treating, compressed natural gas (CNG) delivery, data analytics, related goods comprising sand mine operations, and technologies; and well site fueling and logistics.

Read Our Latest Research Report on LBRT